“Incidence of Adverse and Safety Events in Individuals With Parkinson’s Disease Treated With Catechol-O-Methyltransferase Inhibitor Opicapone As an Add-on to Levodopa Treatment: A Systematic Review and Meta-Analysis”. 2025. Prospects in Pharmaceutical Sciences 23 (4): 175-85. https://doi.org/10.56782/pps.563.